WEKO3
アイテム
{"_buckets": {"deposit": "0ee84f9e-bf0b-49f8-840b-6610c755c400"}, "_deposit": {"created_by": 2, "id": "1044", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "1044"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00001044", "sets": ["9"]}, "author_link": ["4963", "4969", "4964", "4960", "4962", "4968", "4967", "4961", "4965", "4966"], "item_2_alternative_title_19": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Evaluation of the Safety of 2.0% Ganciclovir Eye Drops for Hospital Preparation"}]}, "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2018-01-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "110", "bibliographicPageStart": "107", "bibliographicVolumeNumber": "138", "bibliographic_titles": [{"bibliographic_title": "薬学雑誌"}, {"bibliographic_title": "YAKUGAKU ZASSHI", "bibliographic_titleLang": "en"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The concentration of ganciclovir eye drops for hospital preparation was changed from 0.5% to 2.0% at the Nagasaki University Hospital from March 2015. We investigated the incidence of side effects in 12 patients using 2.0% ganciclovir eye drops and evaluated the cytotoxicity of 2.0% ganciclovir eye drops using cultured rabbit corneal cells in vitro. As a side effect of 2.0% ganciclovir eye drops, three patients exhibited an early feeling of transient stimulation. The 2.0% ganciclovir eye drops did not demonstrate cell cytotoxicity for cultured corneal cells after 5 min, but did after 10 min. These findings suggested that the 2.0% ganciclovir eye drops can be used without corneal epithelium disorder in clinical settings.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Yakugaku Zasshi, 138(1), pp.107-110; 2018", "subitem_description_type": "Other"}]}, "item_2_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "4965", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Nakagawa, Hiroo"}]}, {"nameIdentifiers": [{"nameIdentifier": "4966", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Matsumaru, Yumi"}]}, {"nameIdentifiers": [{"nameIdentifier": "4967", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Nose, Seiichi"}]}, {"nameIdentifiers": [{"nameIdentifier": "4968", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Sasaki, Hitoshi"}]}, {"nameIdentifiers": [{"nameIdentifier": "4969", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Kitahara, Takashi"}]}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本薬学会"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1248/yakushi.17-00015", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c 2018 The Pharmaceutical Society of Japan"}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00316903", "subitem_source_identifier_type": "ISSN"}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "13475231", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_62": {"attribute_name": "出版者別言語", "attribute_value_mlt": [{"subitem_text_value": "Pharmaceutical Society of Japan"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "中川, 博雄"}], "nameIdentifiers": [{"nameIdentifier": "4960", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "松丸, 由美"}], "nameIdentifiers": [{"nameIdentifier": "4961", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "能勢, 誠一"}], "nameIdentifiers": [{"nameIdentifier": "4962", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "佐々木, 均"}], "nameIdentifiers": [{"nameIdentifier": "4963", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "北原, 隆志"}], "nameIdentifiers": [{"nameIdentifier": "4964", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-18"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "YakZas138_107.pdf", "filesize": [{"value": "226.5 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 226500.0, "url": {"label": "YakZas138_107.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/1044/files/YakZas138_107.pdf"}, "version_id": "1715898a-e31f-4d31-9a35-acd388402a88"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "2.0% ganciclovir eye drop", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Corneal cell", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Cytotoxicity", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Hospital preparation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Side effect", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "院内製剤2.0%ガンシクロビル点眼液の安全性に関する検討", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "院内製剤2.0%ガンシクロビル点眼液の安全性に関する検討"}]}, "item_type_id": "2", "owner": "2", "path": ["9"], "permalink_uri": "http://hdl.handle.net/10069/38288", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-06-08"}, "publish_date": "2018-06-08", "publish_status": "0", "recid": "1044", "relation": {}, "relation_version_is_last": true, "title": ["院内製剤2.0%ガンシクロビル点眼液の安全性に関する検討"], "weko_shared_id": -1}
院内製剤2.0%ガンシクロビル点眼液の安全性に関する検討
http://hdl.handle.net/10069/38288
http://hdl.handle.net/10069/38288ac21f429-dfe2-4836-ac31-aa631cc0d03e
名前 / ファイル | ライセンス | アクション |
---|---|---|
YakZas138_107.pdf (226.5 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-06-08 | |||||
タイトル | ||||||
タイトル | 院内製剤2.0%ガンシクロビル点眼液の安全性に関する検討 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 2.0% ganciclovir eye drop | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Corneal cell | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Cytotoxicity | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Hospital preparation | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Side effect | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
中川, 博雄
× 中川, 博雄× 松丸, 由美× 能勢, 誠一× 佐々木, 均× 北原, 隆志 |
|||||
著者別名 | ||||||
姓名 | Nakagawa, Hiroo | |||||
著者別名 | ||||||
姓名 | Matsumaru, Yumi | |||||
著者別名 | ||||||
姓名 | Nose, Seiichi | |||||
著者別名 | ||||||
姓名 | Sasaki, Hitoshi | |||||
著者別名 | ||||||
姓名 | Kitahara, Takashi | |||||
その他のタイトル | ||||||
その他のタイトル | Evaluation of the Safety of 2.0% Ganciclovir Eye Drops for Hospital Preparation | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The concentration of ganciclovir eye drops for hospital preparation was changed from 0.5% to 2.0% at the Nagasaki University Hospital from March 2015. We investigated the incidence of side effects in 12 patients using 2.0% ganciclovir eye drops and evaluated the cytotoxicity of 2.0% ganciclovir eye drops using cultured rabbit corneal cells in vitro. As a side effect of 2.0% ganciclovir eye drops, three patients exhibited an early feeling of transient stimulation. The 2.0% ganciclovir eye drops did not demonstrate cell cytotoxicity for cultured corneal cells after 5 min, but did after 10 min. These findings suggested that the 2.0% ganciclovir eye drops can be used without corneal epithelium disorder in clinical settings. | |||||
書誌情報 |
薬学雑誌 en : YAKUGAKU ZASSHI 巻 138, 号 1, p. 107-110, 発行日 2018-01-01 |
|||||
出版者 | ||||||
出版者 | 日本薬学会 | |||||
出版者別言語 | ||||||
Pharmaceutical Society of Japan | ||||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00316903 | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 13475231 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1248/yakushi.17-00015 | |||||
権利 | ||||||
権利情報 | c 2018 The Pharmaceutical Society of Japan | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Yakugaku Zasshi, 138(1), pp.107-110; 2018 |